Dennison T Veru - Net Worth and Insider Trading
Dennison T Veru Net Worth
The estimated net worth of Dennison T Veru is at least $21,534 dollars as of 2024-06-10. Dennison T Veru is the Director of Fresh Tracks Therapeutics Inc and owns about 22,908 shares of Fresh Tracks Therapeutics Inc (FRTX) stock worth over $21,534. Details can be seen in Dennison T Veru's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Dennison T Veru has not made any transactions after 2020-09-16 and currently still holds the listed stock(s).
Transaction Summary of Dennison T Veru
Dennison T Veru Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Dennison T Veru owns 3 companies in total, including Fresh Tracks Therapeutics Inc (FRTX) , Anchiano Therapeutics Ltd (CMMB) , and Chemomab Therapeutics Ltd (CMMB) .
Click here to see the complete history of Dennison T Veru’s form 4 insider trades.
Insider Ownership Summary of Dennison T Veru
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| FRTX | Fresh Tracks Therapeutics Inc | 2021-06-14 | director |
| CMMB | Anchiano Therapeutics Ltd | 2020-01-01 | director |
| CMMB | Chemomab Therapeutics Ltd | 2020-01-01 | director |
Dennison T Veru Latest Holdings Summary
Dennison T Veru currently owns a total of 1 stock. Dennison T Veru owns 22,908 shares of Fresh Tracks Therapeutics Inc (FRTX) as of September 16, 2020, with a value of $21,534.
Latest Holdings of Dennison T Veru
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| FRTX | Fresh Tracks Therapeutics Inc | 2020-09-16 | 22,908 | 0.94 | 21,534 |
Holding Weightings of Dennison T Veru
Dennison T Veru Form 4 Trading Tracker
According to the SEC Form 4 filings, Dennison T Veru has made a total of 1 transactions in Fresh Tracks Therapeutics Inc (FRTX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Fresh Tracks Therapeutics Inc is the acquisition of 667 shares on September 16, 2020, which cost Dennison T Veru around $24,300.
Insider Trading History of Dennison T Veru
- 1
Dennison T Veru Trading Performance
GuruFocus tracks the stock performance after each of Dennison T Veru's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Dennison T Veru is -15.16%. GuruFocus also compares Dennison T Veru's trading performance to market benchmark return within the same time period. The performance of stocks bought by Dennison T Veru within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Dennison T Veru's insider trading performs compared to the benchmark.
Performance of Dennison T Veru
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 14.74 | | | | | |
| Relative Return to S&P 500(%) | 11.84 | | | | | |
Dennison T Veru Ownership Network
Dennison T Veru Owned Company Details
What does Fresh Tracks Therapeutics Inc do?
Who are the key executives at Fresh Tracks Therapeutics Inc?
Dennison T Veru is the director of Fresh Tracks Therapeutics Inc. Other key executives at Fresh Tracks Therapeutics Inc include Chief Medical Officer Monica E. Luchi , director & CHAIRMAN OF THE BOARD Reginald L Hardy , and General Counsel and CCO David R. Mcavoy .
Fresh Tracks Therapeutics Inc (FRTX) Insider Trades Summary
Over the past 18 months, Dennison T Veru made no insider transaction in Fresh Tracks Therapeutics Inc (FRTX). Other recent insider transactions involving Fresh Tracks Therapeutics Inc (FRTX) include a net sale of 110 shares made by ,
In summary, during the past 3 months, insiders sold 0 shares of Fresh Tracks Therapeutics Inc (FRTX) in total and bought 386,399 shares, with a net purchase of 386,399 shares. During the past 18 months, 110 shares of Fresh Tracks Therapeutics Inc (FRTX) were sold and 680,912 shares were bought by its insiders, resulting in a net purchase of 680,802 shares.
Fresh Tracks Therapeutics Inc (FRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Fresh Tracks Therapeutics Inc Insider Transactions
Dennison T Veru Mailing Address
Above is the net worth, insider trading, and ownership report for Dennison T Veru. You might contact Dennison T Veru via mailing address: C/o Palidade Capital, One Bridge Plaza North #695, Fort Lee Nj 07024.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
